Efficacy and Safety of a Single-pill Fixed Combination of Sufficient Losartan/Hydrochlorothiazide in Chinese Hypertensive Patients
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 180 participants.
Also called NCT03946514
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 180 participants
- Registry
-
NCT03946514
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT03946514. Randomized; no masking; primary purpose treatment. Start 2018-09-01 (actual); primary completion 2024-08-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of a Single-pill Fixed Combination of Sufficient Losartan/Hydrochlorothiazide in Chinese Hypertensive Patients
- Condition
- Hypertension
- Intervention (Drug)
- losartan/hydrochlorothiazide
- Intervention (Drug)
- amlodipine/hydrochlorothiazide
- Lead sponsor
- Shanghai Jiao Tong University School of Medicine
Record details
- Record id
cardio:ct-nct03946514- Content hash
3dd09cc817b625db712633c16e6f0d5744e3ae04039a514a02ad1c1f768683b9